Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Cancer Res ; 61(17): 6451-8, 2001 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-11522640

RESUMO

Immunization to multiple defined tumor antigens for specific immune therapy of human cancer has thus far proven difficult. Eighteen HLA A*0201(+) patients with metastatic melanoma received injections s.c. of CD34(+)progenitor-derived autologous dendritic cells (DCs), which included Langerhans cells. DCs were pulsed with peptides derived from four melanoma antigens [(MelAgs) MelanA/MART-1, tyrosinase, MAGE-3, and gp100], as well as influenza matrix peptide (Flu-MP) and keyhole limpet hemocyanin (KLH) as control antigens. Overall immunological effects were assessed by comparing response profiles using marginal likelihood scores. DC injections were well tolerated except for progressive vitiligo in two patients. DCs induced an immune response to control antigens (KLH, Flu-MP) in 16 of 18 patients. An enhanced immune response to one or more MelAgs was seen in these same 16 patients, including 10 patients who responded to >2 MelAgs. The two patients failing to respond to both control and tumor antigens experienced rapid tumor progression. Of 17 patients with evaluable disease, 6 of 7 patients with immunity to two or less MelAgs had progressive disease 10 weeks after study entry, in contrast to tumor progression in only 1 of 10 patients with immunity to >2 MelAgs. Regression of >1 tumor metastases were observed in seven of these patients. The overall immunity to MelAgs after DC vaccination is associated with clinical outcome (P = 0.015).


Assuntos
Antígenos CD34/imunologia , Vacinas Anticâncer/imunologia , Vacinas Anticâncer/uso terapêutico , Células Dendríticas/imunologia , Melanoma/imunologia , Melanoma/terapia , Adulto , Idoso , Antígenos de Neoplasias/imunologia , Linfócitos T CD8-Positivos/imunologia , Vacinas Anticâncer/efeitos adversos , Feminino , Antígeno HLA-A2/imunologia , Hemocianinas/imunologia , Humanos , Hipersensibilidade Tardia/imunologia , Imunoterapia Adotiva/métodos , Células de Langerhans/imunologia , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
2.
Arch Pediatr ; 22(10): 1021-6, 2015 Oct.
Artigo em Francês | MEDLINE | ID: mdl-26299913

RESUMO

INTRODUCTION: Early-onset neonatal infection remains a major cause of morbidity and mortality in neonates. Both universal vaginal screening for group-B streptococcus (GBS) and intrapartum antibiotic prophylaxis have decreased the incidence of early-onset GBS disease. Almost 12 years after the implementation of the French recommendations, we assessed the practices around screening, diagnosis, and treatment of early-onset neonatal infection in the Île-de-France region. PATIENTS AND METHODS: We conducted a prospective, multicenter, observational study in 14 volunteer maternity wards from 18 to 31 March 2013. All live newborn infants delivered at 35 gestational weeks or more were eligible. Maternal, obstetrical, and neonatal characteristics were collected, as well as the management of suspected early-onset neonatal infections. RESULTS: A total of 1194 mothers and 1217 neonates were included. Among the latter, 54% had bacteriological samplings at birth, with at least a gastric aspirate. Bacteriological samples were collected at birth in 85% of cases based on major or minor anamnestic infection criteria defined by the French National Authority for Health in 2002. In addition, 26% of neonates had at least one blood sample taken. Antibiotic treatment was administered in 4% of the infants with cefotaxime administered in two thirds of cases. CONCLUSION: An update of the French guidelines for the management of early-onset neonatal infections is required in order to improve targeting of newborn infants suspected of having an infection and to optimize the antibiotics administered. Moreover, the role of bacteriological sampling at birth needs to be clarified.


Assuntos
Infecções Bacterianas/diagnóstico , Padrões de Prática Médica/estatística & dados numéricos , Adulto , Antibacterianos/uso terapêutico , Bactérias/isolamento & purificação , Infecções Bacterianas/tratamento farmacológico , Proteína C-Reativa/análise , Feminino , França , Suco Gástrico/microbiologia , Fidelidade a Diretrizes/estatística & dados numéricos , Unidades Hospitalares , Humanos , Recém-Nascido , Transmissão Vertical de Doenças Infecciosas , Guias de Prática Clínica como Assunto , Gravidez , Complicações Infecciosas na Gravidez , Estudos Prospectivos
3.
Arch Pediatr ; 9(3): 255-61, 2002 Mar.
Artigo em Francês | MEDLINE | ID: mdl-11938536

RESUMO

OBJECTIVE: To evaluate the number of hospitalizations due to community-acquired rotavirus acute gastroenteritis in a general pediatric unit during a four-year survey. RESULTS: From January 1997 to December 2000, 725 patients were admitted for acute gastro-enteritis to the general paediatric unit of a Parisian children hospital (nosocomial diarrhoea excluded) and 706 (97.5%) of these patients had had a stool microbiologic examination. Diarrhoea was caused by rotavirus in 359 patients (50.89%) and Salmonella sp in 61 (8.6%). Children and infants hospitalized for rotavirus acute gastroenteritis were younger (26% had three months or less, and 50.03% had six months or less) than in other European studies. CONCLUSION: This study is the first in France reporting a systematic survey of hospitalized gastroenteritis during four years. More than half of hospitalized community-acquired gastroenteritis were due to rotavirus in this Parisian area. The young age of patients should be investigated in other French areas, searching for risk factors and rotavirus strains.


Assuntos
Gastroenterite/virologia , Hospitalização/estatística & dados numéricos , Infecções por Rotavirus , Doença Aguda , Inquéritos Epidemiológicos , Humanos , Lactente , Índice de Gravidade de Doença
4.
Arch Pediatr ; 21(9): 961-7, 2014 Sep.
Artigo em Francês | MEDLINE | ID: mdl-24726672

RESUMO

UNLABELLED: Tracheal intubation in neonates is a painful procedure performed daily in the delivery room despite the widespread development of noninvasive ventilation. Specific analgesia is not commonly performed. The objective of this observational study was to compare practices between two level-III centers: one with a specific protocol for premedication before tracheal intubation of newborns in the delivery room, the other without. RESULTS: One hundred and fifteen neonates were intubated in the delivery room and included over a 4-month period: 25% of them received specific premedication before intubation, exclusively in the center with the protocol. None of the extreme premature neonates (age≤28 gestational weeks) received analgosedation before the procedure. Nalbuphine, midazolam, and sufentanil were mainly used, via the intravenous or intrarectal route. Infants receiving a premedication were significantly heavier and had a greater gestational age than the others (1500 g [range, 1180-2260 g] vs. 1170 [range, 860-1680 g] P=0.003, and 31 GW [range, 29-34 GW] vs. 29 [range, 27-32 GW] P=0.014, respectively). Most pediatricians (85-100%) favored a specific protocol for sedation before tracheal intubation. Implementation of a specific protocol allows specific analgesia to be implemented for newborns undergoing tracheal intubation. Further studies should be conducted to determine the best strategies for pain management during tracheal intubation of neonates, especially in the delivery room.


Assuntos
Analgésicos/uso terapêutico , Protocolos Clínicos , Salas de Parto , Intubação Intratraqueal , Dor/prevenção & controle , Pré-Medicação , Peso Corporal , França , Idade Gestacional , Humanos , Recém-Nascido , Síndrome do Desconforto Respiratório do Recém-Nascido/terapia
5.
Arch Pediatr ; 17 Suppl 4: S184-7, 2010 Sep.
Artigo em Francês | MEDLINE | ID: mdl-20826330

RESUMO

A neonatal infection with Enterobacter cloacae was diagnosed at day 21 in a premature infant. Five cerebral abscesses were discovered 6 days while a treatment with cefotaxim and amikacin was administered. We switched for axepim during 4 weeks and ciprofloxacin until complete regression of cerebral abscesses. At 13 months of age, the infant neurodevelopmental outcome was normal. Ciprofloxacin indications and tolerance during neonatal period are discussed.


Assuntos
Ciprofloxacina/uso terapêutico , Infecções por Enterobacteriaceae/tratamento farmacológico , Recém-Nascido Prematuro , Amicacina/uso terapêutico , Antibacterianos/uso terapêutico , Cefepima , Cefalosporinas/uso terapêutico , Enterobacter cloacae , Infecções por Enterobacteriaceae/diagnóstico , Humanos , Lactente , Recém-Nascido , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA